首页 | 本学科首页   官方微博 | 高级检索  
     

化疗治疗神经胶质瘤的研究进展
引用本文:陈军,罗林,左频,等. 化疗治疗神经胶质瘤的研究进展[J]. 肿瘤药学, 2014, 0(3): 162-165
作者姓名:陈军  罗林  左频  
作者单位:云南省肿瘤医院神经外科,云南昆明650118
摘    要:胶质瘤(Glioma)是成人脑肿瘤中最常见的颅内恶性肿瘤。手术、术后替莫唑胺(Temozolomide, TMZ)联合放疗以及替莫唑胺辅助化疗是目前胶质瘤的标准治疗方案。尽管如此,神经胶质瘤的预后仍然很差。本文主要介绍神经胶质瘤的综合治疗,尤其是化学治疗的相关研究进展。

关 键 词:神经胶质瘤  血肿瘤屏障  化疗  替莫唑胺

Research Progress of the Chemotherapy in the Treatment of Glioma
CHEN Jun,LUO Lin,ZUO Pin,YUAN Hongping,LAI Jun. Research Progress of the Chemotherapy in the Treatment of Glioma[J]. Anti-Tumor Pharmacy, 2014, 0(3): 162-165
Authors:CHEN Jun  LUO Lin  ZUO Pin  YUAN Hongping  LAI Jun
Affiliation:(Department of Neurosurgery, the Tumor Hospital of Yunnan Province, Kunming, Yunnan, 650118, China)
Abstract:Gliobma is one of the most common intracranial malignant tumors in the adult brain tumors. Surgery, temo-zolomide combined with radiotherapy postoperatively and adjuvant chemotherapy with temozolomide have been established as the standard treatment options for glioma. Nevertheless, the prognosis for the patient with gliomas remains poor. This ar-ticle introduces the comprehensive treatment for the glioma, especially the progress on chemotherapy.
Keywords:Glioma  Blood-tumor-barrier  Chemotherapy  Temozolomide
本文献已被 维普 等数据库收录!
点击此处可从《肿瘤药学》浏览原始摘要信息
点击此处可从《肿瘤药学》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号